US Stocks
/
Century Therapeutics, Inc. Share Price
Century Therapeutics, Inc. Share Price

Century Therapeutics, Inc. Share Price

NASDAQ: IPSC | Micro Cap
$1.27
-$0.03 (-1.92%) Last updated on 08 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Century Therapeutics, Inc. Stock Performance

Open
$1.28
Prev. Close
$1.30
Circuit Range
N/A
Day Range
$1.27 - $1.31
Year Range
$0.44 - $3.04
Volume
96,364
Average Traded
$1.31

Century Therapeutics, Inc. Share Price Today

As of 8 October 2026, Century Therapeutics, Inc.'s share price is $1.27. The stock opened at $1.28, compared to its previous close of $1.30. During today's trading session, Century Therapeutics, Inc.'s share price traded between $1.27 and $1.31, with an average price of $1.29. Over the past 52 weeks, the stock has recorded a high of $3.04 and a low of $0.44. In terms of performance, Century Therapeutics, Inc.'s share price has declined by 44.32% over the last six months and is up 118.32% on a year-on-year basis.

Century Therapeutics, Inc. Share Price Chart

$1.27$1.31
L
Show Current Price
H

Century Therapeutics, Inc. Stock Fundamentals & Key Indicators

Market Cap
$110.36M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-0.61
Revenue (TTM)
$109.16B
Return On Equity (TTM)
-47.25%
Profit Margin
-8.78%
Debt to Equity
0.00
Quarterly Earnings Growth YoY
-0.38%

Century Therapeutics, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$34.42-$19.17-$21.65-$34.55
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A44.31%-12.94%-59.58%

Century Therapeutics, Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$5.20$2.24$6.59$109.16
Net Profit-$130.93-$136.67-$126.57-$9.58
Net Profit Margin-2517.88%-6101.34%-1920.64%-8.78%
Income ChangeN/A-4.38%7.39%92.43%

About Century Therapeutics, Inc.

Century Therapeutics Inc is a biotechnology company harnessing the power of allogeneic pluripotent stem cell therapies to develop potentially curative cell therapy products for autoimmune diseases, including type 1 diabetes, or T1D, and cancer. Its beta islet, T cell and NK cell programs are allogeneic, meaning it is derived from healthy donors for use in any patient, rather than being sourced from an individual for their own specific use, as is the case with autologous T cells. The cell types it can generate from iPSCs, including iPSC-derived beta islet cells, iPSC-derived CD4+ and CD8+ alphabeta T cells, or alphabeta iT cells, and iPSC- natural killer cells, or iNK cells.

Century Therapeutics, Inc. Historical Returns

MonthOpenCloseChange %
Oct 2026
$1.67
$1.27
-25.22%
Sep 2026
$2.00
$1.71
-23.54%
Aug 2026
$2.01
$2.23
+10.12%
Jul 2026
$2.44
$2.02
-17.35%
Jun 2026
$2.43
$2.45
+0.20%
May 2026
$2.33
$2.44
+6.77%
Apr 2026
$2.32
$2.29
+1.33%
Mar 2026
$2.27
$2.26
-2.59%
Feb 2026
$1.88
$2.32
+21.78%
Jan 2026
$1.03
$1.91
+95.18%
Dec 2025
$0.54
$0.98
+78.75%
Nov 2025
$0.59
$0.55
-6.51%

IPSC Share Price FAQs

What is Century Therapeutics, Inc. share price today?

chevron-up
Century Therapeutics, Inc. share price today is $1.27 as on October 8, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of Century Therapeutics, Inc. stock?

chevron-up
The 52 week high of Century Therapeutics, Inc. stock is $3.04, while the 52 week low is $0.44 as of 8 Oct '26.

What is IPSC's market capitalisation today?

chevron-up
IPSC market capitalisation is $110.36M as of October 8, 2026, at 4:07 pm IST.

What is IPSC's net income for the last quarter?

chevron-up
IPSC's net income for the last quarter is -34.55B USD.

What is the 5 year returns of IPSC?

chevron-up
The 5 year returns of IPSC is -94.33% as on 8 Oct '26.

What is the high & low stock price of IPSC today?

chevron-up
IPSC stock price hit a high of $1.31 and low of $1.27 as of 8 Oct '26.

Can I buy IPSC shares in India?

chevron-up
Yes. You can buy IPSC in India by opening an international trading account.